Roggeri, D.P. et al. 2020. Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective. Farmeconomia. Health economics and therapeutic pathways. 21, 1 (Jun. 2020). DOI:https://doi.org/10.7175/fe.v21i1.1472.